does glp 1 lower sex drive Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don't 'see' it MTP 115: GLP-1 and Libido:

Bianco, A

By modifying Keap1 cysteine residues, ITCs stabilize Nrf2, leading to enhanced transcription of antioxidant response elements and phase II detoxification enzymes (113)

Provider and patient attitudes vary, but there exists much more reluctance to initiate pharmacotherapy for obesity than for other chronic diseases such as hypertension, type 2 diabetes, or hyperlipidemia

doi: 10.3892/mmr.2011.651

(PubMed) Bougma K, Aboud FE, Harding KB, Marquis GS

The high specificity of Ipamorelin, coupled with the broader impact profile of GHRP-2, seems to allow researchers to design nuanced experiments that probe both targeted and systemic phenomena